Newtyn Management, LLC - Q3 2023 holdings

$405 Million is the total value of Newtyn Management, LLC's 46 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 21.7% .

 Value Shares↓ Weighting
CNNE BuyCANNAE HLDGS INC$53,467,181
+31.6%
2,868,411
+42.7%
13.20%
+37.5%
IAC BuyIAC INC$46,862,700
-17.1%
930,000
+3.3%
11.57%
-13.4%
PAR BuyPAR TECHNOLOGY CORP$37,866,591
+27.8%
982,527
+9.2%
9.35%
+33.5%
MACK  MERRIMACK PHARMACEUTICALS IN$23,102,647
+0.2%
1,873,6940.0%5.70%
+4.7%
BuyARDAGH METAL PACKAGING S A$22,498,872
-14.5%
7,188,138
+2.7%
5.55%
-10.7%
GIII SellG III APPAREL GROUP LTD$20,404,895
-35.6%
818,816
-50.2%
5.04%
-32.8%
SPB  SPECTRUM BRANDS HLDGS INC NE$19,582,564
+0.4%
249,9370.0%4.83%
+4.9%
VTOL BuyBRISTOW GROUP INC$19,518,880
+0.8%
692,896
+2.8%
4.82%
+5.3%
TBPH BuyTHERAVANCE BIOPHARMA INC$15,892,663
-6.4%
1,841,560
+12.3%
3.92%
-2.2%
CIO BuyCITY OFFICE REIT INC$13,515,000
-20.7%
3,180,000
+3.9%
3.34%
-17.1%
Buy2SEVENTY BIO INC$12,059,841
+61.5%
3,076,490
+317.0%
2.98%
+68.7%
GTX SellGARRETT MOTION INC$10,524,307
-6.2%
1,335,572
-9.9%
2.60%
-2.0%
MBI BuyMBIA INC$10,274,250
-14.8%
1,425,000
+2.2%
2.54%
-10.9%
GLPG BuyGALAPAGOS NVspon adr$9,501,250
-13.5%
275,000
+1.9%
2.34%
-9.6%
NewBV FINL INC$8,863,757879,341
+100.0%
2.19%
CYT BuyCYTEIR THERAPEUTICS INC$7,101,261
+101.1%
2,500,444
+84.1%
1.75%
+110.2%
NODK BuyNI HLDGS INC$6,048,900
-11.4%
470,000
+2.2%
1.49%
-7.5%
 FORUM ENERGY TECHNOLOGIES INnote 9.000% 8/0$5,387,904
-0.8%
5,483,8720.0%1.33%
+3.7%
TLYS SellTILLYS INCcl a$5,377,446
-4.1%
662,247
-17.2%
1.33%
+0.2%
PFSW SellPFSWEB INC$5,296,930
+57.0%
711,953
-4.6%
1.31%
+64.0%
PHAT SellPHATHOM PHARMACEUTICALS INC$5,185,000
-47.0%
500,000
-26.9%
1.28%
-44.7%
FET BuyFORUM ENERGY TECHNOLOGIES IN$4,402,866
-4.4%
183,300
+1.8%
1.09%
-0.1%
PCG  PG&E CORP$4,337,696
-6.7%
268,9210.0%1.07%
-2.5%
BuySTAR HLDGS$4,087,430
-14.1%
326,472
+0.6%
1.01%
-10.2%
 ALGOMA STL GROUP INC$4,018,113
-4.2%
590,8990.0%0.99%
+0.1%
ETNB Buy89BIO INC$3,095,720
-18.3%
200,500
+0.2%
0.76%
-14.6%
AVRO NewAVROBIO INC$3,080,0002,000,000
+100.0%
0.76%
WVE BuyWAVE LIFE SCIENCES LTD$2,932,500
+61.1%
510,000
+2.0%
0.72%
+68.4%
KOD BuyKODIAK SCIENCES INC$2,895,649
-57.6%
1,608,694
+62.5%
0.72%
-55.7%
DXLG SellDESTINATION XL GROUP INC$2,688,000
-50.1%
600,000
-45.5%
0.66%
-47.9%
SellORION OFFICE REIT INC$2,473,296
-83.7%
474,721
-79.3%
0.61%
-82.9%
OLMA SellOLEMA PHARMACEUTICALS INC$1,852,500
+17.2%
150,000
-14.3%
0.46%
+22.5%
AIV NewAPARTMENT INVT & MGMT COcl a$1,576,682231,865
+100.0%
0.39%
ADVM BuyADVERUM BIOTECHNOLOGIES INC$1,537,500
-3.3%
1,025,000
+2.5%
0.38%
+0.8%
SNSE SellSENSEI BIOTHERAPEUTICS INC$1,350,180
-35.2%
1,800,000
-1.5%
0.33%
-32.3%
GRPH NewGRAPHITE BIO INC$1,345,740542,637
+100.0%
0.33%
AVIR BuyATEA PHARMACEUTICALS INC$1,200,000
+259.7%
400,000
+348.4%
0.30%
+274.7%
BOLT BuyBOLT BIOTHERAPEUTICS INC$1,060,800
-17.1%
1,020,000
+2.0%
0.26%
-13.2%
MRSN NewMERSANA THERAPEUTICS INC$889,000700,000
+100.0%
0.22%
ALGS BuyALIGOS THERAPEUTICS INC$687,240
-21.4%
920,000
+2.2%
0.17%
-17.5%
ABIO SellARCA BIOPHARMA INC$603,000
-5.2%
300,000
-4.2%
0.15%
-0.7%
BDTX BuyBLACK DIAMOND THERAPEUTICS I$588,350
-41.7%
205,000
+2.5%
0.14%
-39.3%
BRLIR  BRILLIANT ACQUISITION CORPright 99/99/9999$95,598
+49.8%
457,4090.0%0.02%
+60.0%
 ARISZ ACQUISITION CORPright 99/99/9999$22,500
+1.4%
250,0000.0%0.01%
+20.0%
 LEAFLY HOLDINGS INC*w exp 02/04/202$19,039
-1.0%
634,6400.0%0.01%0.0%
VHAQRT  VIVEON HEALTH ACQUISITION COright 12/31/2025$12,750
-11.0%
250,0000.0%0.00%0.0%
ExitGLOBAL BUSINESS TRAVEL GROUP$0-30,923
-100.0%
-0.05%
LW ExitLAMB WESTON HLDGS INC$0-2,157
-100.0%
-0.06%
DBTX ExitDECIBEL THERAPEUTICS INC$0-200,000
-100.0%
-0.18%
PRTK ExitPARATEK PHARMACEUTICALS INC$0-764,274
-100.0%
-0.40%
AMPY ExitAMPLIFY ENERGY CORP NEW$0-393,214
-100.0%
-0.63%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC33Q2 202124.0%
NI HLDGS INC27Q3 20232.9%
ADIENT PLC26Q1 202317.3%
MERRIMACK PHARMACEUTICALS IN25Q3 20235.7%
PG&E CORP24Q3 202319.2%
SPECTRUM BRANDS HLDGS INC NE21Q3 20236.7%
RAFAEL HLDGS INC18Q2 20227.4%
CUSTOMERS BANCORP INC18Q1 20233.7%
BRISTOW GROUP INC14Q3 20234.8%
APPLIED OPTOELECTRONICS INC14Q3 20212.2%

View Newtyn Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Newtyn Management, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20231,206,5025.3%
Garrett Motion Inc.February 14, 20221,571,4512.4%
Flexion Therapeutics IncNovember 24, 20214,400,0008.7%
FLOTEK INDUSTRIES INC/CN/February 16, 20212,789,0593.8%
Forward Pharma A/SSold outFebruary 16, 202100.0%
Pfenex Inc.October 02, 2020650,0001.9%
CymaBay Therapeutics, Inc.Sold outFebruary 14, 202000.0%
Recro Pharma, Inc.Sold outFebruary 14, 202000.0%
Stable Road Acquisition Corp.February 14, 2020700,0003.9%
CSW INDUSTRIALS, INC.February 14, 2017330,0002.1%

View Newtyn Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-08
SC 13D/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13D/A2024-02-13
SC 13D/A2024-01-25

View Newtyn Management, LLC's complete filings history.

Compare quarters

Export Newtyn Management, LLC's holdings